# Inspire Medical Systems, Inc.: filings

INSP · NYSE · CIK 1609550 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/insp.md) · [Financials](/companies/insp/financials.md) · [Filings](/companies/insp/filings.md) · [Insiders](/companies/insp/insiders.md)

## Reports and events: 147 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 549, 8-K 101, 144 56, 3 33, 10-Q 26, SC 13G/A 19, SCHEDULE 13G/A 11, SC 13G 10, SCHEDULE 13G 10, 10-K 8, DEF 14A 8, DEFA14A 8, 4/A 7, CORRESP 5, 424B5 4, ARS 4, 424B4 2, 5 2, D 2, DRS 2, EFFECT 2, S-1 2, S-1/A 2, S-8 2, SD 2, UPLOAD 2, 8-A12B 1, CERT 1, DEFR14A 1, DRS/A 1, DRSLTR 1, FWP 1, PRE 14A 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-03 | 16:07 ET | [10-Q](/filings/0001609550-26-000047.md) | Quarterly report, period 2026-06-30 | 0001609550-26-000047 |
| 2026-08-03 | 16:03 ET | [8-K](/filings/0001609550-26-000045.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-26-000045 |
| 2026-07-24 | 16:01 ET | [8-K](/filings/0001609550-26-000041.md) | 5.02 Departure or appointment of officers or directors | 0001609550-26-000041 |
| 2026-07-22 | 08:02 ET | [8-K](/filings/0001609550-26-000038.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001609550-26-000038 |
| 2026-06-26 | 06:41 ET | [8-K](/filings/0001609550-26-000035.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-26-000035 |
| 2026-05-05 | 16:01 ET | [8-K](/filings/0001609550-26-000026.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001609550-26-000026 |
| 2026-05-04 | 16:07 ET | [10-Q](/filings/0001609550-26-000023.md) | Quarterly report, period 2026-03-31 | 0001609550-26-000023 |
| 2026-05-04 | 16:03 ET | [8-K](/filings/0001609550-26-000021.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-26-000021 |
| 2026-03-20 | 07:51 ET | [DEF 14A](/filings/0001140361-26-010490.md) | Proxy statement, period 2026-04-30 | 0001140361-26-010490 |
| 2026-02-13 | 16:05 ET | [10-K](/filings/0001609550-26-000016.md) | Annual report, period 2025-12-31 | 0001609550-26-000016 |
| 2026-02-11 | 16:32 ET | [8-K](/filings/0001609550-26-000012.md) | 2.02 Results of operations; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-26-000012 |
| 2026-01-12 | 17:04 ET | [8-K](/filings/0001609550-26-000006.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-26-000006 |
| 2025-11-17 | 16:36 ET | [8-K](/filings/0001609550-25-000055.md) | 8.01 Other events | 0001609550-25-000055 |
| 2025-11-03 | 16:07 ET | [10-Q](/filings/0001609550-25-000053.md) | Quarterly report, period 2025-09-30 | 0001609550-25-000053 |
| 2025-11-03 | 16:03 ET | [8-K](/filings/0001609550-25-000052.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-25-000052 |
| 2025-10-10 | 06:53 ET | [8-K](/filings/0001609550-25-000046.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-25-000046 |
| 2025-08-26 | 17:02 ET | [8-K](/filings/0001609550-25-000040.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-25-000040 |
| 2025-08-11 | 16:16 ET | [8-K](/filings/0001609550-25-000035.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001609550-25-000035 |
| 2025-08-04 | 16:16 ET | [10-Q](/filings/0001609550-25-000032.md) | Quarterly report, period 2025-06-30 | 0001609550-25-000032 |
| 2025-08-04 | 16:10 ET | [8-K](/filings/0001609550-25-000030.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-25-000030 |
| 2025-06-13 | 06:19 ET | [8-K](/filings/0001609550-25-000025.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-25-000025 |
| 2025-05-05 | 16:27 ET | [10-Q](/filings/0001609550-25-000020.md) | Quarterly report, period 2025-03-31 | 0001609550-25-000020 |
| 2025-05-05 | 16:11 ET | [8-K](/filings/0001609550-25-000019.md) | 5.07 Shareholder vote results | 0001609550-25-000019 |
| 2025-05-05 | 16:03 ET | [8-K](/filings/0001609550-25-000018.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-25-000018 |
| 2025-03-18 | 16:05 ET | [DEF 14A](/filings/0001140361-25-009249.md) | Proxy statement, period 2025-05-01 | 0001140361-25-009249 |
| 2025-02-10 | 16:23 ET | [10-K](/filings/0001609550-25-000011.md) | Annual report, period 2024-12-31 | 0001609550-25-000011 |
| 2025-02-10 | 16:05 ET | [8-K](/filings/0001609550-25-000009.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-25-000009 |
| 2025-01-13 | 06:48 ET | [8-K](/filings/0001609550-25-000003.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-25-000003 |
| 2024-11-12 | 06:30 ET | [8-K](/filings/0001609550-24-000055.md) | 8.01 Other events | 0001609550-24-000055 |
| 2024-11-04 | 16:18 ET | [10-Q](/filings/0001609550-24-000053.md) | Quarterly report, period 2024-09-30 | 0001609550-24-000053 |
| 2024-11-04 | 16:03 ET | [8-K](/filings/0001609550-24-000050.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-24-000050 |
| 2024-08-06 | 16:07 ET | [10-Q](/filings/0001609550-24-000044.md) | Quarterly report, period 2024-06-30 | 0001609550-24-000044 |
| 2024-08-06 | 16:04 ET | [8-K](/filings/0001609550-24-000042.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001609550-24-000042 |
| 2024-08-02 | 08:05 ET | [8-K](/filings/0001609550-24-000036.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001609550-24-000036 |
| 2024-07-29 | 06:46 ET | [8-K](/filings/0001609550-24-000034.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001609550-24-000034 |
| 2024-07-22 | 17:01 ET | [8-K](/filings/0001609550-24-000032.md) | 5.02 Departure or appointment of officers or directors | 0001609550-24-000032 |
| 2024-05-07 | 16:43 ET | [8-K](/filings/0001609550-24-000028.md) | 5.07 Shareholder vote results | 0001609550-24-000028 |
| 2024-05-07 | 16:07 ET | [10-Q](/filings/0001609550-24-000026.md) | Quarterly report, period 2024-03-31 | 0001609550-24-000026 |
| 2024-05-07 | 16:02 ET | [8-K](/filings/0001609550-24-000024.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-24-000024 |
| 2024-03-19 | 16:31 ET | [DEF 14A](/filings/0001140361-24-014155.md) | Proxy statement, period 2024-05-02 | 0001140361-24-014155 |
| 2024-02-09 | 16:02 ET | [10-K](/filings/0001609550-24-000016.md) | Annual report, period 2023-12-31 | 0001609550-24-000016 |
| 2024-02-06 | 16:08 ET | [8-K](/filings/0001609550-24-000013.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-24-000013 |
| 2024-02-05 | 16:03 ET | [8-K](/filings/0001609550-24-000011.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001609550-24-000011 |
| 2024-01-26 | 16:17 ET | [8-K](/filings/0001609550-24-000008.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001609550-24-000008 |
| 2024-01-08 | 08:03 ET | [8-K](/filings/0001609550-24-000004.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-24-000004 |
| 2023-12-28 | 08:01 ET | [8-K](/filings/0001104659-23-129879.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-23-129879 |
| 2023-11-07 | 16:51 ET | [8-K](/filings/0001609550-23-000065.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-23-000065 |
| 2023-11-07 | 16:27 ET | [10-Q](/filings/0001609550-23-000063.md) | Quarterly report, period 2023-09-30 | 0001609550-23-000063 |
| 2023-11-07 | 16:04 ET | [8-K](/filings/0001609550-23-000061.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001609550-23-000061 |
| 2023-08-01 | 16:57 ET | [8-K](/filings/0001609550-23-000054.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001609550-23-000054 |

Page 1 of 3. [Older](/companies/insp/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 13:56 ET. No prices; not investment advice.